Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Importance of Viability for Response to Cardiac Resynchronization Therapy

NCT00955539 is registered in ClinicalTrials.gov with University Hospital, Gentofte, Copenhagen as lead sponsor.

NCT NCT00955539
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00955539 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Importance of Viability for Response to Cardiac Resynchronization Therapy
Lead sponsor
University Hospital, Gentofte, Copenhagen
Phase
Not applicable
Overall status
Unknown status
Start date
August 31, 2009
Completion date
June 30, 2013
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, ischemic cardiomyopathy